Cell (In Press)Original article
Localized PD-1 CAR T therapy reprograms neuroinflammation
Data ReadoutpositivePD-1 CAR T therapyPositive
AI Analysis
Summary
Researchers demonstrated that programmable PD-1-targeting CAR T cells selectively eliminate pathogenic T follicular helper-like cells and deliver IL-10 at inflammation sites to suppress neuroinflammation in preclinical multiple sclerosis models.
Outcome Details
Programmable PD-1-targeting CAR T cells selectively eliminated pathogenic CD4 T cells while delivering IL-10 at inflammation sites, suppressing neuroinflammation across preclinical models
Importance:4/10
Sentiment:
0.70
CAR-TMultiple sclerosisImmunologyPreclinicalPD-1Neuroinflammation
Read the original article
Published by Cell (In Press) on July 21, 2026 12:00 AM